Aug 30, 2024

Featuring a slide presentation and related discussion from Dr Michiel van der Heijden, including the following topics:

• Efficacy and safety data from the Phase III EV-302/KEYNOTE-A39 trial comparing enfortumab vedotin/pembrolizumab to chemotherapy for patients with previously untreated metastatic urothelial bladder...

Aug 30, 2024

Featuring an interview with Dr Michiel van der Heijden, including the following topics:

• Underlying biological mechanisms of the bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition (0:00)
• Treatment patterns and survival outcomes for patients admitted to the intensive care...

Aug 29, 2024

Featuring a slide presentation and related discussion from Dr Priyanka Sharma, including the following topics:

• Biomarker Assays in the Identification and Prognostication of Patients with Breast Cancer (0:00)
• Utility of Circulating Tumor DNA in the Prognostication of Localized Breast Cancer (24:28)
• Treatment of...

Aug 23, 2024

Featuring an interview with Prof Giuseppe Curigliano, including the following topics:

• Counseling patients with newly diagnosed metastatic breast cancer (mBC); role of patient-reported outcomes and advocacy (0:00)
• Individualized selection of up-front therapy for patients with HR-positive, HER2-negative mBC (6:02)

Aug 22, 2024

Featuring an interview with Dr Angeles Alvarez Secord, including the following topics:

• Front-line management of ovarian cancer (0:00)
• Management of relapsed/refractory ovarian cancer (20:06)
• Management of microsatellite instability-high/mismatch repair-deficient endometrial cancer (23:20)
• Management of microsatellite...